Imaging of Thoracic Malignancies

  • Subba R. Digumarthy
  • Suzanne L. Aquino
Part of the Cancer Treatment and Research book series (CTAR, volume 143)

Technological advances have revolutionized the radiologic imaging of malignancy with tremendous improvements in disease localization and characterization. There has been a great emphasis on extensive research and its clinical application in oncologic imaging.

Thoracic malignancies form an important group of malignancies involving the body. In this chapter, we review the current concepts in imaging of primary and metastatic thoracic malignancies.


Standard Uptake Value Pulmonary Metastasis Carcinoid Tumor Malignant Pleural Mesothelioma Malignant Mesothelioma 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ginsberg MS. Epidemiology of lung cancer. Semin Roentgenol 2005; 40(2): 83–84.PubMedGoogle Scholar
  2. 2.
    Pawel DJ, Puskin JS: The U.S. Environmental Protection Agency’s assessmet of risks from indoor radon. Health Phys 2000; 87: 68–74Google Scholar
  3. 3.
    Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981: 66:1191–1308.PubMedGoogle Scholar
  4. 4.
    Fry WA, Menck HR, Winchester DP. The National Cancer Data Base report on lung cancer. Cancer 1996; 77:1947–55.PubMedGoogle Scholar
  5. 5.
    Zwirewich CV, Vedal S, Miller RR, et al. Solitary pulmonary nodule: high resolution CT and radiologic-pathologic correlation. Radiology 1991; 179: 469–481.PubMedGoogle Scholar
  6. 6.
    Zerhouni EA, Stilik FP, Siegelman SS, et al. CT of the pulmonary nodule: a co-operative study. Radiology 1986; 160: 319–327.PubMedGoogle Scholar
  7. 7.
    Mirtcheva RM, Vazquez M, Yankelevitz DF, et al. Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features presenting as ground-glass opacities on CT. J Clin Imaging 2002; 26:95–100.Google Scholar
  8. 8.
    Gaeta M, Caruso R, Barone M, et al. Ground-glass attenuation in nodular bronchioloalveolar carcinoma: CT patterns and prognostic value. J Comput Assist Tomogr 1998; 22:215–9.PubMedGoogle Scholar
  9. 9.
    Henschke CI, Yankelevitz DF, Mirtcheva R, et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. Am J Roentgenol 2002; 178:1053–7.Google Scholar
  10. 10.
    Kim EA, Johkoh T, Lee KS, et al. Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: pathologic and prognostic implications. Am J Roentgenol 2001; 177:1417–22.Google Scholar
  11. 11.
    Asamura H, Suzuki K, Watanabe S, et al. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann Thorac Sug 2003; 76:1016–22.Google Scholar
  12. 12.
    Aquino SL, Chiles C, Halford P. Distinction of consolidative bronchioloalveolar carcinoma from pneumonia: do CT criteria work? AJR Am J Roentgenol 1998; 171:359–63.PubMedGoogle Scholar
  13. 13.
    Jung JI, Kim H, Park SH, et al. CT differentiation of pneumonic-type bronchioloalveolar cell carcinoma and infectious pneumonia. Br J Radiol 2001; 74:490–4.PubMedGoogle Scholar
  14. 14.
    Shah RM, Friedman AC. CT angiogram sign: incidence and significance in lobar consolidations evaluated by contrast-enhanced CT. Am J Roentgenol 1998; 170:719–21.Google Scholar
  15. 15.
    Murayama S, Onitsuka H, Murakami J, et al. “CT angiogram sign” in obstructive pneumonitis and pneumonia. J Comput Assist Tomogr 1993; 17:609–12.PubMedGoogle Scholar
  16. 16.
    Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg.1988 Sep;96(3):440–7. Erratum in: J Thorac Cardiovasc Surg 1989 Mar;97(3):350PubMedGoogle Scholar
  17. 17.
    Regnard JF, Santelmo N, Romdhani N, et al. Bronchioloalveolar lung carcinoma: results of surgical treatment and prognostic factors. Chest 1998; 114:45–50.PubMedGoogle Scholar
  18. 18.
    Takasugi JE, Rapoport S, Shaw C. Superior sulcus tumors: the role of imaging. J Thorac Imaging 1989; 4:41–8.PubMedGoogle Scholar
  19. 19.
    Heelan RT, Demas BE, Caravelli JF, et al. Superior sulcus tumors: CT and MR imaging. Radiology 1989;170:637–41.PubMedGoogle Scholar
  20. 20.
    Laissy JP, Soyer P, Sekkal SR, et al. Assessment of vascular involvement with magnetic resonance angiography (MRA) in Pancoast syndrome. Magn Reson Imaging 1995; 13:523–30.PubMedGoogle Scholar
  21. 21.
    Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710–7.PubMedGoogle Scholar
  22. 22. Staging Lung Cancer. June 2000
  23. 23.
    Swensen SJ, Brown LR, Colby TV, et al. Lung nodule enhancement at CT: prospective findings. Radiology 1996; 201: 447–455.PubMedGoogle Scholar
  24. 24.
    Padovani B, Mouroux J, Seksik L, et al. Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging. Radiology 1993; 187:33–8.PubMedGoogle Scholar
  25. 25.
    Glazer HS, Duncan-Meyer J, Aronberg DJ, et al. Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation. Radiology 1985; 157:191–4.PubMedGoogle Scholar
  26. 26.
    Ratto GB, Piacenza G, Frola C, et al. Chest wall involvement by lung cancer: computed tomographic detection and results of operation. Ann Thorac Surg 1991; 51:182–8.PubMedGoogle Scholar
  27. 27.
    Pennes DR, Glazer GM, Wimbish KJ, et al. Chest wall invasion by lung cancer: limitations of CT evaluation. AJR Am J Roentgenol 1985; 144:507–11.PubMedGoogle Scholar
  28. 28.
    Pearlberg JL, Sandler MA, Beute GH, et al. Limitations of CT in evaluation of neoplasms involving chest wall. J Comput Assist Tomogr 1987;11:290–3.PubMedGoogle Scholar
  29. 29.
    Scott IR, Müller NL, Miller RR, et al. Resectable Stage III lung cancer: CT, surgical, and pathologic correlation. Radiology 1988; 166(1 Pt 1):75–9PubMedGoogle Scholar
  30. 30.
    Uhrmeister P, Allmann KH, Wertzel H, et al. Chest wall infiltration by lung cancer: value of thin-sectional CT with different reconstruction algorithms. Eur Radiol 1999; 9:1304–9.PubMedGoogle Scholar
  31. 31.
    Shiotani S, Sugimura K, Sugihara M, et al. Diagnosis of chest wall invasion by lung cancer: useful criteria for exclusion of the possibility of chest wall invasion with MR imaging. Radiat Med 2000; 18:283–90.PubMedGoogle Scholar
  32. 32.
    Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer. Ann Intern Med 2003; 139:879–92.PubMedGoogle Scholar
  33. 33.
    Cerfolio RJ, Ojha B, Bryant AS, et al. The role of FDG-PET scan in staging patients with non-small cell carcinoma. Ann Thorac Surg 2003; 76:861–6.PubMedGoogle Scholar
  34. 34.
    Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003; 229:526–33.PubMedGoogle Scholar
  35. 35.
    Lardinois D, Weder W, Hany TF, et al. Staging of non-small cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348: 2500–2507.PubMedGoogle Scholar
  36. 36.
    Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline: update 2003. J Clin Oncol 2004; 22:330–53.PubMedGoogle Scholar
  37. 37.
    Quint LE, Tummala S, Brisson LJ, et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg 1996;62:246–50.PubMedGoogle Scholar
  38. 38.
    Cox JE, Chiles C. Extrathoracic staging of non-small cell lung cancer. In: Taveras JM, Ferrucci JT, editors. Radiology diagnosis-imaging-intervention. Philadelphia: Lippincott-Raven Publishers, 1998:1–17.Google Scholar
  39. 39.
    Salbeck R, Grau HC, Artmann H. Cerebral tumor staging in patients with bronchial carcinoma by computed tomography. Cancer 1990; 66:2007–11.PubMedGoogle Scholar
  40. 40.
    Sze G, Milano E, Johnson C, Heier L. Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 1990; 11:785–91.PubMedGoogle Scholar
  41. 41.
    Baker ME, Pelley R.Hepatic metastases: basic principles and implications for radiologists. Radiology 1995 Nov;197(2):329–37PubMedGoogle Scholar
  42. 42.
    Del Frate C, Bazzocchi M, Mortele KJ etal. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MRI examinations. Radiology 2002;225:766–772.PubMedGoogle Scholar
  43. 43.
    Danet IM, Semelka RC, Leonardou P et al. Spectrum of MRI appearances of untreated metastases of the liver. Am J Roentgenol. 2003 Sep;181(3):809–17.Google Scholar
  44. 44.
    Gilman MD, Aquino SL. State-of-the-Art FDG-PET imaging of lung cancer. Semin Roentgenol 2005 Apr;40(2):143–53. ReviewPubMedGoogle Scholar
  45. 45.
    Dunnick NR, Korobkin M. Imaging of adrenal incidentalomas: current status. Am J Roentgenol 2002;179:559–68.Google Scholar
  46. 46.
    Caoili EM, Korobkin M, Francis IR, et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 2002;222:629–33.PubMedGoogle Scholar
  47. 47.
    K.-Y. Lam, C.-Y. Lo. Metastatic tumors of the adrenal glands: a 30-year experience in a teaching hospital. Clin Endocrinol 2002;56(1) 95–101Google Scholar
  48. 48.
    Pieterman RM, van Putten JWG, Meuzelaar JJ, et al. Preoperative staging of non-small cell lung cancer with positron-emission tomography. N Engl J Med 2000; 343:254–61.PubMedGoogle Scholar
  49. 49.
    Cerfolio RJ, Ojha B, Bryant AS, et al. The role of FDG-PET scan in staging patients with non-small cell carcinoma. Ann Thorac Surg 2003; 76:861–6.PubMedGoogle Scholar
  50. 50.
    Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline: update 2003. J Clin Oncol 2004;22:330–53.PubMedGoogle Scholar
  51. 51.
    Schumacher T, Brink I, Mix M, et al. FDG-PET imaging for the staging and follow-up of small cell lung cancer. Eur J Nucl Med 2001; 28:483–8.PubMedGoogle Scholar
  52. 52.
    Pandit N, Gonen M, Krug L, et al. Prognostic value of [18F] FDG-PET imaging in small cell lung cancer. Eur J Nucl Med 2003; 30:78–84.Google Scholar
  53. 53.
    Perez EA, Loprinzi CL, Sloan JA, et al. Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma. Cancer 1997; 80:676–80.PubMedGoogle Scholar
  54. 54.
    Iglesias M, Belda J, Baldo X et al. Bronchial Carcinoid Tumor: a retrospective Analysis of 62 Surgically Treated Cases. Arch Bronconeumol. 2004 May;40 (5):218–21.PubMedGoogle Scholar
  55. 55.
    Jeung MY, Gasser B, Gangi A, et al. Bronchial carcinoid tumors of the thorax: spectrum of radiologic findings. RadioGraphics 2002; 22:351–65.PubMedGoogle Scholar
  56. 56.
    Magid D, Siegelman SS, Eggleston JC, et al. Pulmonary carcinoid tumors: CT assessment. J Comput Assist Tomogr 1989; 13:244–7.PubMedGoogle Scholar
  57. 57.
    Zwiebel BR, Austin JH, Brimes MM. Bronchial carcinoid tumors: assessment with CT of location and intratumoral calcification in 31 patients. Radiology 1991;179:483–6.PubMedGoogle Scholar
  58. 58.
    Paillas W, Moro-Sibilot D, Lantuejoul S, Brichon PY, Coulomb M, Ferretti G. Bronchial carcinoid tumors: role of imaging for diagnosis and local staging. J Radiol 2004; 85: 1711–9.PubMedGoogle Scholar
  59. 59.
    Naidich DP. CT/MR correlation in the evaluation of tracheobronchial neoplasia. Radiol Clin North Am 1990; 28:555–571.PubMedGoogle Scholar
  60. 60.
    Aronchick JM, Wexler JA, Christen B, et al. Computed tomography of bronchial carcinoid. J Comput Assist Tomogr 1986; 10:71–4.PubMedGoogle Scholar
  61. 61.
    Granberg D, Sundin A, Janson ET, Oberg K, Skogseid B, Westlin JE. Octreoscan in patients with bronchial carcinoid tumors. Clin Endocrinol (Oxf) 2003 Dec; 59(6):793–9.Google Scholar
  62. 62.
    Erasmus, JJ, McAdams HP, Patz EF Jr, et al. Evaluation of primary pulmonary carcinoid tumors using FDG PET. Am J Roentgenol 1998; 170:1369–73Google Scholar
  63. 63.
    A.J. van der Molan, M.Prokop. Neck. Chapter in Spiral and multislice computed tomography of the body. M. Prokop & M. Galanski. Thieme 2003. 261–62Google Scholar
  64. 64.
    C.Schaefer-Prokop, M. Prokop.Lungs and tracheobronchial system. Chapter in Spiral and multislice computed tomography of the body. M. Prokop & M. Galanski. Thieme 2003. 324–327Google Scholar
  65. 65.
    Berkman N, Breuer R, Kramer M, Polliack A. Pulmonary involvement in lymphoma. Leuk Lymphoma 1996;20:229–237.PubMedGoogle Scholar
  66. 66.
    Lewis E, Caskey C, Fishman E. Lymphoma of the lung: CT findings in 31 patients. Am J Roentgenol 1991; 156:711–714.Google Scholar
  67. 67.
    Sorensen J.B. Endobronchial metastases from extrapulmonary solid tumors. Acta Oncol 2004; 43(1):73–79.PubMedGoogle Scholar
  68. 68.
    Al-Mehdi AB, Tozawa K, Fisher AB, et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000; 6:100–2.PubMedGoogle Scholar
  69. 69.
    Wong CW, Song C, Grimes MM, et al. Intravascular location of breast cancer cells after spontaneous metastasis to the lung. Am J Pathol 2002; 161:749–53.PubMedGoogle Scholar
  70. 70.
    Milne EN, Zerhouni EA. Blood supply of pulmonary metastases. J Thorac Imaging 1987; 2:15–23.PubMedGoogle Scholar
  71. 71.
    Stackpole CW. Intrapulmonary spread of established B16 melanoma lung metastases and lung colonies. Invasion Metastasis 1990; 10:267–80.PubMedGoogle Scholar
  72. 72.
    Alterman AL, Fornabaio DM, Stackpole CW. Metastatic dissemination of B16 melanoma: pattern and sequence of metastasis. J Natl Cancer Inst 1985; 75:691–702.PubMedGoogle Scholar
  73. 73.
    Primack SL, Hartman TE, Lee KS, et al. Pulmonary nodules and the CT halo sign. Radiology 1994; 190:513–5.PubMedGoogle Scholar
  74. 74.
    Patel A, Ryu J. Angiosarcoma in the lung. Chest 1993; 103:1531–1535.PubMedGoogle Scholar
  75. 75.
    Benditt JO, Farber HW, Wright J, et al. Pulmonary hemorrhage with diffuse alveolar infiltrates in men with high-volume choriocarcinoma. Ann Intern Med 1988; 109:674–5.PubMedGoogle Scholar
  76. 76.
    Chalmers N, Best JJ. The significance of pulmonary nodules detected by CT but not by chest radiography in tumor staging. Clin Radiol 1991; 44:410–412.PubMedGoogle Scholar
  77. 77.
    Kronawitter U, Kemeny NE, Heelan R, et al. Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer 1999; 86:229–235.PubMedGoogle Scholar
  78. 78.
    Picci P, Vanel D, Briccoli A, et al. Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. Ann Oncol 2001; 12:1601–4PubMedGoogle Scholar
  79. 79.
    Lim DJ, Carter MF. Computerized tomography in the preoperative staging for pulmonary metastases in patients with renal cell carcinoma. J Urol 1993;150:1112–4.PubMedGoogle Scholar
  80. 80.
    Heaston DK, Putman CE, Rodan BA, et al. Solitary pulmonary metastases in high-risk melanoma patients: a prospective comparison of conventional and computed tomography. AJR Am J Roentgenol 1983; 141:169–74.PubMedGoogle Scholar
  81. 81.
    Yamada H, Katoh H, Kondo S, et al. Surgical treatment of pulmonary recurrence after hepatectomy for colorectal liver metastases. Hepatogastroenterology 2002; 49:976–979.PubMedGoogle Scholar
  82. 82.
    Koong HN, Pastorino U, Ginsberg RJ. Is there a role for pneumonectomy in pulmonary metastases? Ann Thorac Surg 1999; 68:2039–2043.PubMedGoogle Scholar
  83. 83.
    Shepard J, Moore E, Templeton P, et al. Pulmonary intravascular tumor emboli: dilated and beaded peripheral pulmonary arteries at CT. Radiology 1993; 187:797–801.PubMedGoogle Scholar
  84. 84.
    Kang C, Choi J, Kim H, et al. Lung metastases manifesting as pulmonary infarction by mucin and tumor embolization: radiographic, high-resolution CT, and pathologic findings. J Comput Assist Tomogr 1999; 23:644–646.PubMedGoogle Scholar
  85. 85.
    Odeh M, Oliven A, Misselevitch I, et al. Acute cor pulmonale due to tumor cell microemboli. Respiration 1997; 64:384–7.PubMedGoogle Scholar
  86. 86.
    Chan CK, Hutcheon MA, Hyland RH, et al. Pulmonary tumor embolism: a critical review of clinical, imaging, and hemodynamic features. J Thorac Imaging 1987; 2:4–14.PubMedGoogle Scholar
  87. 87.
    Schriner RW, Ryu JH, Edwards WD. Microscopic pulmonary tumor embolism causing subacute cor pulmonale: a difficult antemortem diagnosis. Mayo Clin Proc 1991; 66:143–8.PubMedGoogle Scholar
  88. 88.
    Majhail NS, Urbain JL, Albani JM, et al. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma. J Clin Oncol 2003; 21:3995–4000.PubMedGoogle Scholar
  89. 89.
    Imdahl A, Reinhardt MJ, Nitzsche EU, et al. Impact of 18F-FDG- positron emission tomography for decision making in colorectal cancer recurrences. Langenbecks Arch Surg 2000; 385:129–34.PubMedGoogle Scholar
  90. 90.
    Hirakata K, Nakata H, Haratake J. Appearance of pulmonary metastases on high-resolution CT scans: comparison with histopathologic findings from autopsy specimens. AJR Am J Roentgenol 1993; 161:37–43.PubMedGoogle Scholar
  91. 91.
    Munk PL, Muller NL, Miller RR, Ostrow DN. Pulmonary lymphangitic carcinomatosis: CT and pathologic findings. Radiology1988;166:705–9PubMedGoogle Scholar
  92. 92.
    Stein MG, Mayo J, Muller N, Aberle DR, Webb WR, Gamsu G. Pulmonary lymphangitic spread of carcinoma: appearance on CT scans. Radiology 1987; 162:371–5.PubMedGoogle Scholar
  93. 93.
    Berkman N, Breuer R, Kramer M, Polliack A. Pulmonary involvement in lymphoma. Leuk Lymphoma 1996; 20:229–237.PubMedGoogle Scholar
  94. 94.
    Tanaka N, Matsumoto T, Miura G, et al. CT findings of leukemic pulmonary infiltration with pathologic correlation. Eur Radiol 2002; 12:166–74.PubMedGoogle Scholar
  95. 95.
    Heyneman LE, Johkoh T, Ward S, et al. Pulmonary leukemic infiltrates: high-resolution CT findings in 10 patients. AJR Am J Roentgenol 2000; 174:517–21.PubMedGoogle Scholar
  96. 96.
    Zerhouni EA, Naidich DP, Stitik FP, et al. Computed tomography of the pulmonary parenchyma. Part 2: Interstitial disease. J Thorac Imaging 1985; 1:54–64PubMedGoogle Scholar
  97. 97.
    Ren H, Hruban RH, Kuhlman JE, et al. Computed tomography of inflation-fixed lungs: the beaded septum sign of pulmonary metastases. J Comput Assist Tomogr 1989; 13:411–6.PubMedGoogle Scholar
  98. 98.
    Williams MP, Husband JE, Heron CW. Intrathoracic manifestations of metastatic testicular seminoma: a comparison of chest radiographic and CT findings. AJR Am J Roentgenol 1987; 149:473–5.PubMedGoogle Scholar
  99. 99.
    Schirrmeister H, Kuhn T, Guhlmann A, et al. Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med 2001; 28:351–8.PubMedGoogle Scholar
  100. 100.
    Barranger E, Grahek D, Antoine M, et al. Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer. Ann Surg Oncol 2003; 10:622–7.PubMedGoogle Scholar
  101. 101.
    van der Hoeven JJ, Hoekstra OS, Comans EF, et al. Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer. Ann Surg 2002; 236:619–24.PubMedGoogle Scholar
  102. 102.
    Kawashima A, Libshitz HI. Malignant pleural mesothelioma: CT manifestations in 50 cases. AJR Am J Roentgenol 1990; 155:965–9.PubMedGoogle Scholar
  103. 103.
    Metintas M, Ucgun I, Elbek O, et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol 2002; 41:1–9.PubMedGoogle Scholar
  104. 104.
    Knuuttila A, Halme M, Kivisaari L, et al. The clinical importance of magnetic resonance imaging versus computed tomography in malignant pleural mesothelioma. Lung Cancer 1998; 22:215–25.PubMedGoogle Scholar
  105. 105.
    Heelan RT, Rusch VW, Begg CB, et al. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol 1999; 172:1039–47.PubMedGoogle Scholar
  106. 106.
    Gerbaudo VH, Sugarbaker DJ, Britz-Cunningham S, et al. Assessment of malignant pleural mesothelioma with 18F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. J Nucl Med 2002; 43:1144–1149.PubMedGoogle Scholar
  107. 107.
    Flores RA, Akhurst TB, Gonen MC, et al. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2003; 126:11–16.PubMedGoogle Scholar
  108. 108.
    Monte SA, Ehya H, Lang WR. Positive effusion cytology as the initial presentation of malignancy. Acta Cytol 1987; 31:448–52.PubMedGoogle Scholar
  109. 109.
    Sahn SA. Malignant pleural effusions. Clin Chest Med 1985; 6:113–25. 101PubMedGoogle Scholar
  110. 110.
    O’Donovan PB, Eng P. Pleural changes in malignant pleural effusions: appearance on computed tomography. Cleve Clin J Med 1994; 61:127–31; quiz 162PubMedGoogle Scholar
  111. 111.
    Yang PC, Luh KT, Chang DB, Wu HD, Yu CJ, Kuo SH. Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. AJR Am J Roentgenol 1992; 159:29–33.PubMedGoogle Scholar
  112. 112.
    Gorg C, Restrepo I, Schwerk WB. Sonography of malignant pleural effusion. Eur Radiol 1997; 7:1195–8.PubMedGoogle Scholar
  113. 113.
    Arenas-Jimenez J, Alonso-Charterina S, Sanchez-Paya J, et al. Evaluation of CT findings for diagnosis of pleural effusions. Eur Radiol 2000; 10:681–90.PubMedGoogle Scholar
  114. 114.
    Gupta NC, Rogers JS, Graeber GM, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion. Chest 2002; 122:1918–1924.PubMedGoogle Scholar
  115. 115.
    Hierholzer J, Luo L, Bittner RC, et al. MRI and CT in the differential diagnosis of pleural disease. Chest 2000; 118:604–9.PubMedGoogle Scholar
  116. 116.
    Carlsen SE, Bergin CJ, Hoppe RT. MRI to detect chest wall and pleural involvement in patients with lymphoma: effect on radiation therapy planning. AJR Am J Roentgenol 1993; 160:1191–5.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Subba R. Digumarthy
    • 1
  • Suzanne L. Aquino
    • 1
  1. 1.Department of RadiologyMassachusetts General HospitalBostonUSA

Personalised recommendations